| 2 | 1/1 | 返回列表 |
| 查看: 712 | 回復(fù): 1 | ||
| 本帖產(chǎn)生 1 個 翻譯EPI ,點擊這里進行查看 | ||
霜葉金蟲 (小有名氣)
|
[求助]
醫(yī)學類摘要翻譯,謝謝
|
|
|
Background: Cisatracurium in clinical practice is devoid of histamine-induced cardiovascular effects. On the other hand, 2 ED95 doses of cisatracurium (100 μ g/kg) do not create satisfactory intubating conditions such as those seen with equipotent doses of atracurium. The recommended intubating dose of cisatracurium is 3 ED95. To understand this discrepancy better, we evaluated the potency and onset of atracurium and cisatracurium. Materials and Methods: The study designed as randomized controlled clinical trial to compare between atracurium (2×ED95) and different doses of cisatracurium (2×ED95, 4×ED95, 6×ED95) regarding onset time, duration of action, condition of intubation, hemodynamic effects, and sings of histamine release clinically. Sixty four patients were randomly assigned to one of four groups, the first group (group 1) received 2×ED95 dose of atracurium, group 2 received 2×ED95 dose of cisatracurium, group 3 received 4×ED95 dose of cisatracurium, while group 4 received 6×ED95 dose of cisatracurium. The Datex relaxograph (Type NMT-100-23-01, S/N: 37541) for neuromuscular monitoring was used. Results: HR, MABP was statistically significant increased post-intubation with administration of 2×ED95 dose of atracurium in group 1 and the same dose of cisatracurium in group 2 but 5-20 min later was not statistically significant with administration of 4×ED95 and 6×ED95 doses of cisatracurium in groups 3 and 4, respectively. Onset time was found to be significantly lower with 2×ED95 dose of atracurium than with the same dose of cisatracurium. At the same time, higher doses of cisatracurium (4×ED95 and 6×ED95) showed onset time and longer duration of action that was significantly lower than with atracurium and with lower dose of cisatracurium (2×ED95). Only 6×ED95 dose of cisatracurium showed statistically significant difference versus the atracurium dose with higher percentages of patients with excellent condition of intubation. 4×ED95 and 6×ED95 doses of cisatracurium were significantly better than 2×ED95 dose of cisatracurium. 2×ED95dose of atracurium and 2×ED95 dose of cisatracurium were similar, while 4×ED95 and 6×ED95 doses of cisatracurium were significantly better than atracurium and 2×ED95 dose of cisatracurium. Conclusion: The same dose (2×ED95 dose) atracurium is more effective neuromuscular blocking agent than cisatracurium, while higher doses of cisatracurium 4×ED95 and 6×ED95 provide more effective, more rapid neuromuscular blocking with longer duration of action, stable hemodynamic status, and no associated signs of histamine release clinically. |
版主 (文壇精英)
|
背景: 在臨床實踐中順式-阿屈庫銨不產(chǎn)生組胺誘導(dǎo)的心血管效應(yīng)。另一方面,2 ED95(95%的有效藥物劑量)劑量順式-阿屈庫銨(100μg / kg以下)不會與等效劑量阿曲庫銨一樣產(chǎn)生滿意的插管條件。 順式-阿屈庫銨的推薦插管劑量為3 ED95。為了理解這種差異更好,我們評價阿曲庫銨和順式-阿屈庫銨的效力和起效時間。 材料和方法: 隨機對照臨床試驗,比較阿曲庫銨(2×ED95)和不同劑量順式-阿屈庫銨(2×ED95,4×ED95,6×ED95)就起效時間,作用時間,插管的狀況,血流動力學影響的研究,和有無胺釋放的臨床跡象。64個病人被隨機分成四組,第一組(第1組)接受2×ED95劑量阿曲庫銨,2組接受2×ED95劑量順式-阿屈庫銨,第3組4×ED95劑量順式-阿屈庫銨,而第4組接收6×ED95順式-阿屈庫銨劑量。該德恩relaxograph(類型NMT-100-23-01,S / N:37541)用于監(jiān)測神經(jīng)肌肉。 結(jié)果: 插管給藥2×ED95劑量阿曲庫銨的第1組和第2組相同劑量順式-阿屈庫銨HR、平均動脈壓有統(tǒng)計學顯著意義(增加);但5-20分鐘后,分別與4×ED95組的第3組和6×ED95的第4組無統(tǒng)計學顯著性。發(fā)病時間2×ED95劑量阿曲庫銨相顯著低于同劑量的順式-阿屈庫銨。與此同時,更高的劑量順式-阿屈庫銨(4×ED95和6×ED95)的顯示發(fā)病時間和較長的作用時間比用阿曲庫銨顯和低劑量順式-阿屈庫銨(2×ED95)短。患者的插管條件優(yōu)越比例較高的阿曲庫銨的劑量只有6×ED95順式-阿屈庫銨的劑量與其有統(tǒng)計顯著性差異。4×ED95和6×ED95劑量順式-阿屈庫銨都顯著大于2×ED95劑量順式-阿屈庫銨。 2×ED95劑量阿曲庫銨和2×ED95劑量順式-阿屈庫銨相似,而4×ED95和6×ED95劑量順式-阿屈庫銨的比阿曲庫銨和2×ED95劑量順式-阿屈庫銨更好。 結(jié)論: 與順式-阿屈庫銨相比,相同的劑量(2×ED95劑量)阿曲庫銨是更為有效的神經(jīng)肌肉阻斷劑,而較高劑量順式-阿屈庫銨4×ED95和6×ED95提供更有效、更快速的神經(jīng)肌肉阻滯,持續(xù)時間長,穩(wěn)定的血液動力學狀態(tài),沒有有關(guān)的組胺釋放的臨床跡象。 |

| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 352分 化工與材料 +3 | 海納百川Ly 2026-03-27 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 274求調(diào)劑 +17 | 顧九笙要謙虛 2026-03-24 | 23/1150 |
|
|
[考研] 308求調(diào)劑 +7 | 墨墨漠 2026-03-25 | 7/350 |
|
|
[考研] 化學308分求調(diào)劑 +8 | 你好明天你好 2026-03-23 | 9/450 |
|
|
[考研] 286求調(diào)劑 +4 | lim0922 2026-03-26 | 4/200 |
|
|
[考研] 材料學碩333求調(diào)劑 +8 | 北道巷 2026-03-24 | 8/400 |
|
|
[考研] 304求調(diào)劑 +3 | 曼殊2266 2026-03-27 | 3/150 |
|
|
[考研] 化學工程085602 305分求調(diào)劑 +17 | RichLi_ 2026-03-25 | 17/850 |
|
|
[考研] 289求調(diào)劑 +17 | 碩星赴 2026-03-23 | 17/850 |
|
|
[考研] 22 350 本科985求調(diào)劑,求老登收留 +4 | 李軼男003 2026-03-20 | 4/200 |
|
|
[考研] 0856求調(diào)劑 +8 | zhn03 2026-03-25 | 9/450 |
|
|
[考研] 化學調(diào)劑一志愿上海交通大學336分-本科上海211 +4 | 小魚愛有機 2026-03-25 | 4/200 |
|
|
[考研] 調(diào)劑310 +3 | 溫柔的晚安 2026-03-25 | 4/200 |
|
|
[考研] 一志愿哈工大,085400,320,求調(diào)劑 +4 | gdlf9999 2026-03-24 | 4/200 |
|
|
[考研] 347求調(diào)劑 +4 | L when 2026-03-25 | 4/200 |
|
|
[考研] 300分,材料,求調(diào)劑,英一數(shù)二 +5 | 超贊的 2026-03-24 | 5/250 |
|
|
[考研] 305分求調(diào)劑(食品工程) +5 | Sxy112 2026-03-21 | 7/350 |
|
|
[考研] 求調(diào)劑 +7 | 十三加油 2026-03-21 | 7/350 |
|
|
[考研] 求調(diào)劑 +4 | 要好好無聊 2026-03-21 | 4/200 |
|
|
[考研] 297求調(diào)劑 +3 | 喜歡還是不甘心 2026-03-20 | 3/150 |
|